NEWS: Ahead of Novo Nordisk Hearing, 250 Clinicians Demand Affordable Access to Ozempic and Wegovy
Physicians and health professionals from around the country demanded that Novo Nordisk and Eli Lilly make their novel diabetes and obesity medications affordable and accessible to all. WASHINGTON, Sept. 16 – Ahead of next week’s hearing, which will focus on the outrageously high prices that Novo Nordisk charges Americans for their blockbuster drugs, Ozempic and Wegovy, Sen. Bernie Sanders (I-Vt.),